Trellus Health soars on AIM debut - a clever creation!
The share price of Trellus Health, another delightfully engineered creation from the Christopher Mills/Harwood Capital/EKF Diagnostics stable, soared on its AIM debut. The valuation looks totally bonkers to us, and indeed probably to EKF who invested in the business for a fraction of the current price a few months ago. EKF holders will nevertheless be delighted as shareholder value is magically enhanced. Read our thoughts here.
Trellus Health (LON:TRLS) is pioneering a new healthcare category called "Resilience-Driven Connected Health" – sounds a bit harsh to us! Trellus believes this approach will transform the management of chronic conditions through the GRITT™ (Gaining Resilience Through Transitions) methodology that was scientifically validated at the Mount Sinai IBD Center, one of the leading Inflammatory Bowel Diseases ("IBD") treatment centres in the United States. Trellus will utilise the GRITT methodology to identify and modify disease interfering behaviours while coordinating and delivering multidisciplinary care via telehealth. It will also remotely monitor clinical and behavioural factors for indicators of rising risk that may lead…